Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook

Go back to Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook

Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q

October 30, 2015 11:54 AM EDT

Leerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00), following the company's 3Q earnings results. 3Q revenues of $1.76B was in-line with consensus, along with of $1.64.

Analyst Richard Newitter commented, "Expectations were low, but ZBH's 3Q... More